Protherics, Advanced In Vitro Cell Technologies S.L., Glenveigh Pharmaceuticals LLC, MacroMed deal

PTI acquired drug delivery company MacroMed for £12.7 million ($25.1 million) in stock. The deal gives PTI OncoGel, a sustained-release formulation of